Latest Breaking News On - நிறுவனம் பாஸ்டர் கொரியா - Page 1 : comparemela.com

Repurposed drugs for COVID-19 treatment identified through virtual screening and cell-based assays A joint research group from KAIST and Institut Pasteur Korea has identified repurposed drugs for COVID-19 treatment through virtual screening and cell-based assays. The research team suggested the strategy for virtual screening with greatly reduced false positives by incorporating pre-docking filtering based on shape similarity and post-docking filtering based on interaction similarity. This strategy will help develop therapeutic medications for COVID-19 and other antiviral diseases more rapidly. This study was reported at the Proceedings of the National Academy of Sciences of the United States of America (PNAS). Researchers screened 6,218 drugs from a collection of FDA-approved drugs or those under clinical trial and identified 38 potential repurposed drugs for COVID-19 with this strategy. Among them, seven compounds inhibited SARS-CoV-2 replication in Vero cells. Three of these dr

United statesDae jangEmily hendersonInstitut pasteur koreaNational academyDistinguished professor sang yupஒன்றுபட்டது மாநிலங்களில்டே ஜங்எமிலி ஹென்டர்சன்நிறுவனம் பாஸ்டர் கொரியாதேசிய கலைக்கழகம்புகழ்பெற்ற ப்ரொஃபெஸர் பாடினார் ஆம்